Prior Restraint: A Bayesian Perspective on the Optimization of Technology Utilization for Diagnosis of Coronary Artery Disease - 28/07/11
Doi : 10.1016/S0002-9149(99)80809-1
George A. Diamond, M.D., Timothy A. Denton, M.D., Daniel S. Berman, M.D., Ishae Cohen, Ph.D.
The Division of Cardiology, Cedars-Sinai Medical Center, and the School of Medicine, University of California, Los Angeles Los Angeles, California, Dr Diamond’s address is. 2408 Wild Oak Drive, Los Angeles, California 90068 Manuscript
Résumé |
According to the U.S. Department of Commerce, healthcare spending totalled $942.5 billion in 1993, and rose another $118 billion in 1994.1 Most physicians think that unnecessary utilization of medical technology is a major contributor to this spending spiral,2 and similar views are voiced both by the general public and by their elected officials3 One Commerce Department economist estimates that unnecessary tests and procedures consumed $130 billion last year alone.1
Le texte complet de cet article est disponible en PDF.© 1995
Elsevier B.V. Tous droits réservés.
Vol 76 - N° 1-2
P. 82-86 - juillet 1995 Retour au numéro
Article précédent
- Exercise Training and Bleed Viscosity in Patients With Ischemic Heart Disease
- Glenn N. Levine, Carol O’Malley, Gary J. Balady
- Usefulness of Endothelin-1 as a Predictor of Response to Head-Up Tilt-Table Testing in Children With Syncope
- Mary Mehta, Grace Wolff, Ming-Lon Young, Madeleen S. Mas, Amelia Escobar, Henry Gelband
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?